Great experience at Medical Fair Thailand 2025—discussing the future of medical device development in Asia and building new connections! #NCC #Cancer #Oncology #ClinicalResearch

🌟ATLAS Monthly Webinar🌟 Speaker Introduction Dr. Nguyen Huong Giang (Vietnam National Cancer Institute) Title: Cancer Registry in Vietnam: Current Status and Opportunities Date: September 30th, 2025 Registration: us06web.zoom.us/webinar/regist…

[ATLAS HP] ATLAS HP international medical care blog "NCC today" has been updated! #31 Supporting Cancer Care with Central Venous Ports: Safe and Reliable IR Procedures atlas.ncc.go.jp/en/internation… #NCC #Cancer #Oncology #ClinicalResearch

🌟ATLAS Monthly Webinar🌟 Speaker Introduction Dr. Siti Norbayah binti Yusof (National Cancer Institute, Malaysia) Title: Cancer Registry and Epidemiology in Malaysia Date: September 30th, 2025 Registration: us06web.zoom.us/webinar/regist…

🌟ATLAS Monthly Webinar🌟 Moderator Introduction Dr. Tomohiro Matsuda (National Cancer Center, Japan) Date: September 30th, 2025 Registration: us06web.zoom.us/webinar/regist…

Welcome Dr. Yunlu Jia (Zhejiang Univ.) as a visiting scholar at NCC (Jul 17–Oct 11, 2025)! Her focus: clinical trial design, precision oncology & immunotherapy. She aims to foster Japan–China collaboration in cancer research.#VisitingScholar #GlobalOncology #TranslationalResearch

ATLAS English website has moved! New URL: atlas.ncc.go.jp/en/ Update your bookmark! ✅

Our Japan team visited the APO office in Bangkok to support the ATLAS ARISE PMDA International Symposium 2025. We are grateful for their dedication and strength driving the ATLAS Project forward! #ATLASProject #internationalteam #APOBangkok

Over 100 registered for our September 30 ATLAS Webinar on Cancer Registration and Epidemiology in Asia! #NCC #Cancer #Oncology #ClinicalResearch

Poster presentation on the OCCC cohort of the A-TRAIN study at #ESMO2025! (Oct 17–21, Berlin) On the right: Dr. David S. P. Tan from (NUH Singapore), on the left: Dr. Kan Yonemori (NCCH Japan) Many thanks to all who contributed to this research. #ATLASProject #NCC #OCCC #Oncology

📢 The CHOICE Study led by Dr. Maruki NCC Japan is now published! It reports on FGFR2 fusion-positive biliary tract cancer in Asia with patients from Thailand, Malaysia, Taiwan & Vietnam. 🔗 [onlinelibrary.wiley.com/doi/10.1111/he…] #CancerResearch #CHOICEStudy #ATLASProject

Visited Siriraj Institute of Clinical Research (SICRES) on Oct 2, 2025 with Clinical Research Malaysia CEO Dr. Akhmal Yusof. We discussed the current state of clinical research in Asia and future collaboration with Prof. Kulkanya Chokephaibulkit and team at SICRES. #collaboration

ATLAS SRCG joined the EORTC STBSG meeting to discuss future collaboration in upcoming sarcoma trials. We sincerely appreciate this valuable opportunity to engage with the team. #ATLASProject #Clinicalresearch #Oncology

We welcomed Dr. Kota Katanoda, Division Chief, Division of Population Data Science, Institute for Cancer Control (NCC Japan), to APO. We shared our activities and discussed collaboration in cancer control and data science. #cancercontrol #datascience #Asia

ATLAS Team visited HSIJB for the ATLAS audit and discussed clinical research activities and future ATLAS development with PI Dr. Chen May Feng. #ATLASProject #CancerResearch #AsiaNetwork

ATLAS Team conducted on-site audit at Hospital Umum Sarawak, meeting PI Dr. Voon Pei Jye, SI Dr. Ang Choon Seong, and Study Coordinators Irene Bragai Ak Segaran and Nur Haziqah Mesran.Special thanks to Ms. Shakirin Kamaruzaman (CRM) for coordination across all sites.#ATLASProject

ATLAS Sarcoma & Rare Cancer Group held its regular meeting. We shared project updates and discussed new study proposals to advance research in sarcoma and rare cancers. #sarcoma #rarecancer #ATLAS

The ATLAS Team visited Hospital Pulau Pinang for an audit and discussed research progress with Dr. Soo Hoo Hwoei Fen. #ATLASProject #CancerResearch #Malaysia

🌟ATLAS Monthly Webinar🌟 Speaker Introduction Dr. Chau Hsien Matthew (National Cancer Centre Singapore, Singapore) Title: Why perioperative immunotherapy should be recommended Date: November 17th, 2025 Registration: us06web.zoom.us/.../reg.../WN_…